← Back to Clinical Trials
Recruiting NCT07803003

NCT07803003 Effects of Maximum Versus Minimum Supervised Telerehabilitation on Upper Limb Function in Post Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07803003
Status Recruiting
Phase —
Sponsor Foundation University Islamabad
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-02-11
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Maximum supervision telerehabilitationMinimum Supervision Telerehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-02-11 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This single-blinded randomized controlled trial aims to compare the effectiveness of maximum versus minimum therapist supervision during home-based telerehabilitation for improving upper limb motor function, task performance, coordination, and proprioception in stroke survivors. The study will be conducted at MDL Rehabilitation FUCP and participants' home settings. A total of 30 stroke survivors aged 40-70 years with mild to moderate upper limb impairment (Fugl-Meyer Assessment of the Upper Extremity \[FM-UE\] score 23-56) and a stroke duration of 3-24 months will be recruited through purposive sampling and randomly allocated to either the maximum- or minimum-supervision group.Participants in the maximum-supervision group will receive three 45-minute videoconference-based telerehabilitation sessions per week, for a total of 24 sessions over eight weeks. Exercises will be individualized according to baseline FM-UE scores. The minimum-supervision group will perform an independent home-based exercise program at the same frequency and duration, supplemented by weekly therapist check-ins and a self-maintained exercise log. Both groups will receive standardized instructional materials, including an exercise booklet and demonstration videos, and will perform exercises within individual fatigue limits.The primary outcomes will be assessed using the Fugl-Meyer Upper Extremity Assessment, Wolf Motor Function Test, Comprehensive Coordination Scale, and Thumb Localization Test, evaluating upper limb motor recovery, functional task performance, coordination, and proprioception.The study is expected to determine whether greater therapist supervision provides superior or comparable outcomes and to contribute evidence for developing effective, scalable, and cost-efficient home-based telerehabilitation models for stroke rehabilitation.

Eligibility Criteria

Inclusion Criteria: * Stroke either ischemic or hemorrhagic clinically diagnosed or confirmed by MRI or CT. * Stroke duration between 3 and 24 months. * Age between 40 and 70 years. * FMA score of 23-56 out of 66 points on the hemiplegic side. * Mini mental state examination score greater than 24 out of 30. * Ability to maintain stable sitting with or without support for at least 30-45 minutes * No serious auditory, memory or visual impairment. * Ability to read,understand and follow instructions in urdu. * Access to a device with internet and video capabilities and basic ability to operate it. * Availability of a caregiver or a family member to assist during sessions if required. Exclusion Criteria: * \- Presence of aphasia or apraxia or unilateral neglect. * Unable to understand or remember or follow commands. * Modified ashworth scale score greater than 3 for spasticity. * History of other brain diseases or brain surgery. * Other causes of severe upper limb dysfunction. * Unstable medical condition or vital organ failure including malignancy. * Inability to cooperate with telerehabilitation procedures.

Contact & Investigator

Central Contact

Tehreem Fatima, DPT

✉ peelupaul4@gmail.com

📞 +923160515404

Frequently Asked Questions

Who can join the NCT07803003 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07803003 currently recruiting?

Yes, NCT07803003 is actively recruiting participants. Contact the research team at peelupaul4@gmail.com for enrollment information.

Where is the NCT07803003 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07803003 clinical trial?

NCT07803003 is sponsored by Foundation University Islamabad. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology